Moderna Faces Complaint To SEC Over Vax Patent Row

By Dean Seal (December 22, 2021, 6:25 PM EST) -- Oxfam America has filed a whistleblower complaint with the U.S. Securities and Exchange Commission that accuses Moderna of misleading shareholders about a fiery patent dispute over its widely distributed COVID-19 vaccine.

The advocacy group said Tuesday that Moderna has not been transparent about its fight with the National Institutes of Health, which is pushing for Moderna to credit three of the agency's scientists with co-inventing the mRNA sequence of Moderna's vaccine.

According to Oxfam, the pharmaceutical company has been portraying patent disputes in its regulatory filings as "purely theoretical in nature" despite the fact that the NIH has openly threatened litigation...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!